Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 196 clinical trials
None
Prophylactic Anticoagulation for Catheter-related Thrombosis

The main objective of this study is to compare the efficacy and safety of aspirin, low molecule heparin and rivaroxaban for preventing catheter-related thrombosis in middle-to-high-risk ambulatory patients with cancer and implantable venous access ports.

  • 0 views
  • 25 Jan, 2021
  • 19 locations
None
Aspirin to Target Arterial Events in Chronic Kidney Disease

This study aims to find out whether people with chronic kidney disease [CKD] should take low dose aspirin to reduce the risk of first heart attack or stroke (cardiovascular disease [CVD]). CKD is common and is associated with an increased risk of CVD. CVD is caused by small blood clots …

aspirin
glomerular filtration rate
nephropathy
cardiovascular disease
chronic disease
  • 0 views
  • 26 Jul, 2021
  • 1 location
None
Eltrombopag for Chemotherapy-induced Thrombocytopenia

To evaluate the efficacy an safety of eltrombopag to treat chemotherapy-induced thrombocytopenia

  • 0 views
  • 11 Jul, 2021
  • 1 location
None
Perioperative Eltrombopag in Patients With Inherited Thrombocytopenia

administration of platelet concentrates (PC) for performing elective invasive acts at mild or high bleeding risk,in selected patients with inherited thrombocytopenia (IT).

  • 0 views
  • 26 Jan, 2021
  • 23 locations
None
Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia

Evaluate the safety and efficacy of Yttrium-90 (90Y) radioembolization for the management of thrombocytopenia.

varicose veins
platelet count
hepatocellular carcinoma
carcinoma
varices
  • 4 views
  • 24 Sep, 2021
  • 1 location
None
Optimizing the Diagnosis of Heparin Induced Thrombocytopenia

Multicentre (Ottawa and Halifax) prospective cohort study using a diagnostic approach in patients clinically suspected to have HIT that combines pretest probability assessment with quantitative interpretation of anti-PF4 assay.

  • 5 views
  • 06 Mar, 2021
  • 1 location
None
Efficacy and Safety of Avatrombopag in Cancer Patients With Thrombocytopenia

To evaluate the efficacy and safety of Avatrombopag in patients with thrombocytopenia induced by targeted therapy and immunotherapy combination treatment, and provide evidence-based medication

avatrombopag
cancer
  • 0 views
  • 30 May, 2021
  • 1 location
None
Avatrombopag in Patients With End-stage Liver Disease and Thrombocytopenia

End stage liver disease is prone to thrombocytopenia. This study is a multi-center, randomized, prospective, randomized controlled Phase IV Clinical trial to discuss the Efficacy and Safety of

platelet count
avatrombopag
cirrhosis
liver disease
  • 0 views
  • 16 Jun, 2021
  • 1 location
None
Romiplostim Rituximab and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia

The purpose of this study is to determine the response rate and response duration with the combination of low-dose rituximab, romiplostim and high-dose dexamethasone.

platelet count
romiplostim
thrombocytopenia
rituximab
dexamethasone
  • 0 views
  • 25 Jan, 2021
  • 1 location
None
Fixed Low-dose Eltrombopag and rhTPO for Immune Thrombocytopenia (FLOWER)

corticosteroid-resistant or relapsed immune thrombocytopenia (ITP) patients during the COVID-19 pandemic.

recombinant human thrombopoietin
autoimmune thrombocytopenia
thrombocytopenia
covid-19
eltrombopag
  • 0 views
  • 26 Jan, 2021
  • 1 location